Relationship between no-visitation policy and the development of delirium in patients admitted to the intensive care unit.
APACHE
Aged
Aged, 80 and over
COVID-19
/ epidemiology
Delirium
/ diagnosis
Female
Humans
Incidence
Intensive Care Units
Length of Stay
Male
Policy
Proportional Hazards Models
Respiration, Artificial
Retrospective Studies
SARS-CoV-2
/ isolation & purification
Visitors to Patients
/ legislation & jurisprudence
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
08
2021
accepted:
22
02
2022
entrez:
9
3
2022
pubmed:
10
3
2022
medline:
18
3
2022
Statut:
epublish
Résumé
Due to the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic, many hospitals imposed a no-visitation policy for visiting patients in hospitals to prevent the transmission of SARS-CoV-2 among visitors and patients. The objective of this study was to investigate the association between the no-visitation policy and delirium in intensive care unit (ICU) patients. This was a single-center, before-after comparative study. Patients were admitted to a mixed medical-surgical ICU from September 6, 2019 to October 18, 2020. Because no-visitation policy was implemented on February 26, 2020, we compared patients admitted after this date (after phase) with the patients admitted before the no-visitation policy (before phase) was implemented. The primary outcome was the incidence of delirium during the ICU stay. Cox regression was used for the primary analysis and was calculated using hazard ratios (HRs) and 95% confidence intervals (CIs). Covariates were age, sex, APACHE II, dementia, emergency surgery, benzodiazepine, and mechanical ventilation use. Of the total 200 patients consecutively recruited, 100 were exposed to a no-visitation policy. The number of patients who developed delirium during ICU stay during the before phase and the after phase were 59 (59%) and 64 (64%), respectively (P = 0.127). The adjusted HR of no-visitation policy for the number of days until the first development of delirium during the ICU stay was 0.895 (0.613-1.306). The no-visitation policy was not associated with the development of delirium in ICU patients.
Sections du résumé
BACKGROUND
Due to the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic, many hospitals imposed a no-visitation policy for visiting patients in hospitals to prevent the transmission of SARS-CoV-2 among visitors and patients. The objective of this study was to investigate the association between the no-visitation policy and delirium in intensive care unit (ICU) patients.
METHODS
This was a single-center, before-after comparative study. Patients were admitted to a mixed medical-surgical ICU from September 6, 2019 to October 18, 2020. Because no-visitation policy was implemented on February 26, 2020, we compared patients admitted after this date (after phase) with the patients admitted before the no-visitation policy (before phase) was implemented. The primary outcome was the incidence of delirium during the ICU stay. Cox regression was used for the primary analysis and was calculated using hazard ratios (HRs) and 95% confidence intervals (CIs). Covariates were age, sex, APACHE II, dementia, emergency surgery, benzodiazepine, and mechanical ventilation use.
RESULTS
Of the total 200 patients consecutively recruited, 100 were exposed to a no-visitation policy. The number of patients who developed delirium during ICU stay during the before phase and the after phase were 59 (59%) and 64 (64%), respectively (P = 0.127). The adjusted HR of no-visitation policy for the number of days until the first development of delirium during the ICU stay was 0.895 (0.613-1.306).
CONCLUSION
The no-visitation policy was not associated with the development of delirium in ICU patients.
Identifiants
pubmed: 35263384
doi: 10.1371/journal.pone.0265082
pii: PONE-D-21-25576
pmc: PMC8906646
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0265082Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Heart Lung. 2016 Jan-Feb;45(1):15-20
pubmed: 26685069
JAMA. 2019 Jul 16;322(3):216-228
pubmed: 31310297
Aust Crit Care. 2005 Feb;18(1):6, 8-9, 11-4 passim
pubmed: 18038529
Crit Care Med. 2017 Nov;45(11):e1111-e1122
pubmed: 28787293
Crit Care Med. 2018 Dec;46(12):2029-2035
pubmed: 30234569
J Clin Epidemiol. 1995 Dec;48(12):1503-10
pubmed: 8543964
Intensive Care Med. 2019 Jan;45(1):1-12
pubmed: 30506354
BMC Med Res Methodol. 2021 May 6;21(1):97
pubmed: 33952189
Crit Care Med. 2017 Oct;45(10):1660-1667
pubmed: 28671901
Arch Intern Med. 2007 Aug 13-27;167(15):1629-34
pubmed: 17698685
Rev Bras Anestesiol. 2012 Jul;62(4):469-83
pubmed: 22793963
J Trauma. 2011 Apr;70(4):910-5
pubmed: 21610396
Crit Care Med. 2018 Jul;46(7):1175-1180
pubmed: 29642108
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
JAMA. 2001 Dec 5;286(21):2703-10
pubmed: 11730446
Crit Care. 2012 Jul 03;16(4):R115
pubmed: 22759376
Crit Care Med. 2015 Jan;43(1):40-7
pubmed: 25251759
J Trauma. 2008 Jul;65(1):34-41
pubmed: 18580517
Anesthesiology. 2006 Jan;104(1):21-6
pubmed: 16394685
Ann Intensive Care. 2012 Dec 31;2(1):51
pubmed: 23272945
Circulation. 2006 Feb 21;113(7):946-52
pubmed: 16490836
Intensive Care Med. 2001 May;27(5):859-64
pubmed: 11430542
Neurotherapeutics. 2012 Jan;9(1):158-75
pubmed: 22270810
BMJ. 2015 Jun 03;350:h2538
pubmed: 26041151
JAMA. 2004 Apr 14;291(14):1753-62
pubmed: 15082703
Intensive Crit Care Nurs. 2020 Feb;56:102763
pubmed: 31668437